Search

Your search keyword '"Booker, Matthew"' showing total 359 results

Search Constraints

Start Over You searched for: Author "Booker, Matthew" Remove constraint Author: "Booker, Matthew"
359 results on '"Booker, Matthew"'

Search Results

1. Open-Source, Cost-Aware Kinematically Feasible Planning for Mobile and Surface Robotics

2. Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

5. KDM6A epigenetically regulates subtype plasticity in small cell lung cancer

6. Self-Exploration in Complex Unknown Environments using Hybrid Map Representation

10. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer

12. How do primary care clinicians approach hospital admission decisions for people in the final year of life? A systematic review and narrative synthesis.

13. Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

15. Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate

17. Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

18. CTLA-4 Blockade Leads to Enrichment of Active CD56dimCD16+ NK Cells and Depletion of Regulatory T Cells Following Infusion of Haploidentical Donor Memory-like Natural Killer Cells Plus IL-15 Superagonist in a Phase 1 Trial

26. FlyRNAi: the Drosophila RNAi screening center database

27. Supplementary Figure 6 from ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

28. Data from ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

31. Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy

32. Abstract 5774: Small cell lung cancer subtype plasticity is regulated by KDM6A

33. Abstract 1201: ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma

34. Supplementary Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy

36. Table S4 from CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells

37. Data from CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells

38. Supplementary Data from CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells

39. Supplementary Figure 5 from ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

40. Supplementary Figure 4 from ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

41. Supplementary Figure 3 from ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

42. Supplementary Tables 1-8 from ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

47. ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

Catalog

Books, media, physical & digital resources